The University of Kansas Health System, commonly known as KU Med and formerly known as The University of Kansas Hospital, is a nonprofit, academic medical center located in Kansas City, Kansas, United States, with branch hospitals and education centers in Topeka, Kansas and Lawrence, Kansas.

There are 910 beds in University of Kansas Hospital.

During the past decade, University of Kansas Hospital conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 42 clinical trials were completed, i.e. on average, 64.6% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 22 clinical trials were completed. i.e. 62.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas Hospital" #1 sponsor was "Boston Scientific Corporation" with 14 trials, followed by "Pfizer" with 11 trials sponsored, "University of Kansas Medical Center" with 10 trials sponsored, "Medical College of Wisconsin" with 8 trials sponsored and "Medtronic Cardiovascular" with 8 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Hospital" #1 collaborator was "Blood and Marrow Transplant Clinical Trials Network" with 11 trials as a collaborator, "National Cancer Institute (NCI)" with 11 trials as a collaborator, "National Marrow Donor Program" with 9 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator and "Canadian Heart Research Centre" with 2 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas Hospital" are "Atrial Fibrillation" (5 trials), "Acute Leukemia" (4 trials), "Severe Aortic Stenosis" (4 trials), "Acute Myeloid Leukemia" (3 trials) and "Aortic Valve Stenosis" (3 trials). Many other conditions were trialed in "University of Kansas Hospital" in a lesser frequency.

Most popular intervention types in "University of Kansas Hospital" are "Drug" (43 trials), "Device" (36 trials), "Biological" (12 trials), "Other" (11 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)" (4 trials), "Cyclophosphamide" (3 trials), "Surgical Aortic Valve Replacement (SAVR)" (3 trials) and "Accordion Pill™ Carbidopa/Levodopa" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas Hospital" are 98 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Kansas Hospital". undefined are not yet recruiting, 19 are recruiting, 15 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 45 completed trials in University of Kansas Hospital, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas Hospital, 7 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 26 trials that are defined as “Not Applicable".